Skip to main content

Find Clinical Trials

Home
Conditions
IDH1-Mutated Malignancies

Clinical trial condition

IDH1-Mutated Malignancies

Explore clinical trials studying IDH1-Mutated Malignancies. Study availability and eligibility vary by location and protocol.

2 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

IDH1-Mutated Malignancies trial results

Recruiting

A Study of an IDH1m Inhibitor in Participants With IDH1-Mutated Malignancies and Hepatic or Renal Impairment

NCT07006688

Conditions: IDH1-Mutated Malignancies
Locations: Emory University Atlanta, Georgia, United States

MD Anderson Houston, Texas, United States

Icon Cancer Centre South Brisbane, Queensland, Australia

Royal Adelaide Hospital Adelaide, South Australia, Australia

View all 19 locations

View Trial Details

Recruiting

Olutasidenib Combined With Co-targeted Therapy in Relapsed or Refractory IDH1-mutated Myeloid Malignancies Harboring Activated Signaling Pathway Mutations

NCT07032727

Conditions: IDH1-Mutated Malignancies, Mutations, Targeted Therapy
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details